[HTML][HTML] Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
Background The virological and immunological effects of the immunomodulatory drugs used
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
[HTML][HTML] Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
M Masiá, M Fernández-González, S Padilla… - …, 2020 - ncbi.nlm.nih.gov
Background The virological and immunological effects of the immunomodulatory drugs used
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
M Masiá, M Fernández-González, S Padilla… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The virological and immunological effects of the immunomodulatory drugs used
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
[HTML][HTML] Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
M Masiá, M Fernández-González, S Padilla, P Ortega… - EBioMedicine, 2020 - Elsevier
Background The virological and immunological effects of the immunomodulatory drugs used
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
[引用][C] Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
M Masiá, M Fernández-González, S Padilla, P Ortega… - EBioMedicine, 2020 - cir.nii.ac.jp
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody
responses in patients with COVID-19: A prospective cohort study | CiNii Research CiNii 国立 …
responses in patients with COVID-19: A prospective cohort study | CiNii Research CiNii 国立 …
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.
M Masiá, M Fernández-González, S Padilla… - Ebiomedicine, 2020 - europepmc.org
Background The virological and immunological effects of the immunomodulatory drugs used
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.
M Masiá, M Fernández-González, S Padilla… - Ebiomedicine, 2020 - europepmc.org
Background The virological and immunological effects of the immunomodulatory drugs used
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …
for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with …